Characterizing Effects of Erenumab on Patients with Menstrually-Related Migraines
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Migraine
-
Age: Between 18 - 55 Years
-
Gender: Female
-
Other Inclusion Criteria:
- Female patients between age 18 – 55 treated at NYU Langone Health
- Diagnosis of migraine headaches
- Current or prior use of erenumab for migraine treatment, for at least 3 consecutive months
You may not be eligible for this study if the following are true:
-
- Does not meet the inclusion criteria
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.